Ultrahigh nanostructured drug payloads from degradable mesoporous silicon aerocrystals

Porous silicon has found increased attention as a drug delivery system due to its unique features such as high drug payloads, surface area and biodegradation. In this study supercritical fluid (SCF) assisted drying of ultrahigh porosity (>90%) silicon particles and flakes was shown to result in much higher mesopore volumes (~4.66 cm³/g) and surface areas (~680 m²/g) than with air-drying. The loading and physical state of the model drug (S)-(+)-Ibuprofen in SCF dried matrices was quantified and assessed using thermogravimetric analysis, differential scanning calorimetry, UV-Vis spectrophotometry, gravimetric analysis, gas adsorption and electron microscopy. Internal drug payloads of up to 72% were achieved which was substantially higher than values published for both conventionally dried porous silicon (17-51%) and other mesoporous materials (7-45%). In-vitro degradability kinetics of SCF-dried matrices in simulated media was also found to be faster than air-dried controls. The in-vitro release studies provided improved but sustained drug dissolution at both pH 2.0 and pH 7.4.

One-step continuous extrusion process for the manufacturing of solid dispersions

The purpose of this study was to evaluate the performance of synthetic magnesium aluminometasilicate (MAS) as a novel inorganic carrier in hot melt extrusion (HME) processing of indomethacin (IND) for the development of solid dispersions. A continuous extrusion process at various IND/excipient blend ratios (20%, 30% and 40%) was performed using a twin-screw extruder. Physicochemical characterization carried out by SEM, DSC, and XRPD demonstrated the presence of IND in amorphous nature within the porous network of the inorganic material for all extruded formulations. Further, AFM and FTIR studies revealed a single-phase amorphous system and intermolecular H-bonding formation. The IND/MAS extrudates showed enhanced INM dissolution rates within 100% been released within 1h. Stability studies under accelerated conditions (40°C, RH 75%) showed that MAS retained the physical stability of the amorphous solid dispersions even at high drug loadings for 12 months.

Formation of hydroxyapatite/biopolymer biomaterials. I. Microporous composites from solidified emulsions

Microporous materials of controlled pore size were prepared by means of a three-step process involving in situ hydrochemical preparation of a hydroxyapatite-sodium caseinate (HAp-Cas) composite material into a Cas-stabilized oil-in-water emulsion, subsequent concentration and drying of the composite-emulsion, and removal of the oil by means of supercritical carbon dioxide extraction. The resulting composite materials were found to contain micron-sized pores in the space previously occupied by the oil droplets. In order to elucidate the structure of the resulting porous product, its Cas-HAp composition was studied in the corresponding nonporous composite material. In nonporous samples, a protein assay by means of visible spectroscopy suggested equilibrium between the Cas that was trapped in the composite structure and the Cas that remained in solution after precipitation. This observation was confirmed by separate thermogravimetric analysis and Fourier transform IR spectroscopy measurements.